Phase 3 Efficacy and Safety Study of Favipiravir for Treatment of Uncomplicated Influenza in Adults - T705US316
Clinical trial NCT02026349 · COMPLETED
Trial details
- NCT number
- NCT02026349
- Sponsor
- MDVI, LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-01
- Primary completion
- 2015-03-01
- Enrollment
- 860
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.